A substrate, pyridine-2-azo-p-dimethylaniline cephalosporin (PADAC; Diagnostic Pasteur, Marnes-LaCoquette, France), for detection of penicillinase-producing Neisseria gonorrhoeae (PPNG) on 
Penicillinase-producing Neisseria gonorrhoeae (PPNG) strains were first isolated in 1976 (6) . Since then, PPNG strains have spread to all continents, and their increase has become a dramatic problem in developing countries for two major reasons: (i) detection of PPNG necessitates costly laboratory investigations before therapy to avoid treatment failure, and (ii) an alternative therapy to penicillin is often more expensive. This is a considerable financial burden for most sexually transmitted disease centers in Africa. Although a rapid method for detection of PPNG in urethral exudates has been developed (2, 3, 8) 
